Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424821
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-12
Brief Title:
Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC
Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Organization:
Shanghai Pulmonary Hospital Shanghai China
Organization Data
Organization:
Shanghai Pulmonary Hospital Shanghai China
Class:
OTHER
Study ID:
2023LY0204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Lead Sponsor Class:
OTHER
Responsible Party:
Chunxia Su
Responsible Party Title:
Director of Clinical Research Center Shanghai Pulmonary Hospital
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Pulmonary Hospital Shanghai China
Old Name:
None
Old Organization:
None